686TiP Preliminary phase I results from a first-in-human study of ZG006, a trispecific anti-T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer or neuroendocrine carcinoma
医学
细胞
CD3型
T细胞
癌症研究
肿瘤科
病理
CD8型
免疫学
免疫系统
遗传学
生物
作者
Q. Wang,Xiaoyun Chai,R H Lin,Liqiang Zheng,Dan Cao,Xiujuan Qu,Lu Liu,Lihua Wu,Hongmei Mou,Qing Xu,Jianguo Shi